§ Mr. DalyellTo ask the Secretary of State for Health (1) what is the policy of national health service laboratories about entering into agreements to pay fees in respect of gene patents;
(2) what advice she is giving in response to patent claims in relation to biotechnology intellectual property, with particular references to the cystic fibrosis gene;
(3) what is her policy in relation to licence fees for the use of polymerase chain reactions.
§ Mr. SackvilleThe subject of intellectual property rights, including those for polymerase chain reaction and gene sequences, is under review.